Lv41
424 积分 2021-02-16 加入
126TiP: An open-label, single-arm, phase Ib exploratory study to evaluate the safety and efficacy of golidocitinib in combination with anti-PD-1 in locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with anti-PD-1 containing regimens
4小时前
已完结
P1.11.74 Phase Ib Study of Golidocitinib Plus Anti-PD-1 in Anti-PD-1 Treated Advanced NSCLC: Dose-Escalation Safety Using BOIN Design
4小时前
求助中
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
2个月前
已完结
Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis
2个月前
已完结
Abstract CT520: The safety summary of the phase 1a/b trial of QL1706, a novel dual immune checkpoint blockade containing a mixture of anti-PD1 IgG4 and anti-CTLA4 IgG1 antibodies, for advanced malignant tumors
3个月前
已关闭
皖公网安备34019202002308
